- Home
- CODA vs CRVO Comparison
CODA vs CRVO Comparison
Compare CODA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- CRVO
- Stock Information
- Founded
- CODA 1994
- CRVO 2001
- Country
- CODA United States
- CRVO United States
- Employees
- CODA N/A
- CRVO N/A
- Industry
- CODA Industrial Machinery/Components
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- CRVO Health Care
- Exchange
- CODA Nasdaq
- CRVO Nasdaq
- Market Cap
- CODA 92.5M
- CRVO 95.4M
- IPO Year
- CODA N/A
- CRVO N/A
- Fundamental
- Price
- CODA $6.05
- CRVO $8.91
- Analyst Decision
- CODA Strong Buy
- CRVO Strong Buy
- Analyst Count
- CODA 1
- CRVO 8
- Target Price
- CODA $11.00
- CRVO $25.43
- AVG Volume (30 Days)
- CODA 16.8K
- CRVO 13.3M
- Earning Date
- CODA 03-17-2025
- CRVO 03-17-2025
- Dividend Yield
- CODA N/A
- CRVO N/A
- EPS Growth
- CODA 61.24
- CRVO N/A
- EPS
- CODA 0.34
- CRVO N/A
- Revenue
- CODA $21,064,685.00
- CRVO $9,737,974.00
- Revenue This Year
- CODA $31.72
- CRVO N/A
- Revenue Next Year
- CODA $12.23
- CRVO N/A
- P/E Ratio
- CODA $18.74
- CRVO N/A
- Revenue Growth
- CODA 15.63
- CRVO 36.29
- 52 Week Low
- CODA $5.66
- CRVO $1.80
- 52 Week High
- CODA $9.89
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- CODA 21.72
- CRVO 63.30
- Support Level
- CODA $6.53
- CRVO $8.53
- Resistance Level
- CODA $7.11
- CRVO $16.94
- Average True Range (ATR)
- CODA 0.44
- CRVO 2.01
- MACD
- CODA -0.03
- CRVO 0.66
- Stochastic Oscillator
- CODA 2.84
- CRVO 50.33
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.